Article
Arginine506 to glutamin mutation in the factor V gene in infancy and childhood: evidence of fibrinolytic impairment.
European journal of pediatrics - 1 Mar 1997
Nowak-Göttl U, Vielhaber H, Grohmann J, Schneppenheim R, Koch H G
Abstract excerpt
UNLABELLED: Resistance to activated protein C (APCR), in the majority of cases due to arginine506 (Arg506) to glutamine (Gln) mutation in the factor V gene, has emerged as the most important hereditary cause of venous thrombo-embolism. To determine to what extent this relatively common gene mutation influences the fibrinolytic system we investigated a population of APC resistant children (n = 65) in comparison...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
